2m 2m 2m 2m 2m 2m 2m
Cellectis Sp ADR (CLLS)
NASDAQ
$2.85-$0.05 (-1.69%)
Price as of Jun 23, 2026 4:49 PM EDT- $204.8MMarket Cap
- 97.28%1-Year Change
- BiotechnologyIndustry
Cellectis Sp ADR (CLLS)
$2.85-$0.05 (-1.69%)
CLLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.90 | ||
Change | +$0.08 (+2.84%) | ||
Open | $2.80 | ||
High | $2.96 | ||
Low | $2.80 | ||
Previous Close | $2.82 | ||
Volume | 7,755 | ||
30-Day Average Volume | 52,913 | ||
1-Week Change | -4.92% | ||
1-Month Change | -17.14% | ||
1-Year Change | 97.28% | ||
3-Year Change | 58.47% | ||
5-Year Change | -80.41% | ||
Fundamentals | |||
Shares Outstanding | 72.6M | ||
Total Assets | $324.7M | ||
Market Cap | $204.8M | ||
Enterprise Value | $143.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue